NEW YORK (AP) - Evidence that global manufacturing is expanding pushed the stock market to an all-time high on Tuesday.
The Dow Jones industrial average climbed within two points of 17,000 for the first time after separate surveys showed that manufacturing expanded in the world's two largest economies. In China, manufacturing grew in June for the first time in six months and in the U.S. the sector notched its 13th straight month of expansion.
General Motors climbed the most in almost a month after reporting that its U.S. sales rose 1 percent in June despite a record-setting string of safety recalls. Netflix jumped after analysts at Goldman Sachs raised their outlook on the stock, predicting the company will benefit from its international expansion.
"The economic news, by and large, isn't bad here," said Phil Orlando, chief equity strategist at Federated Investors. "Maybe investors are starting to think that this thing is going to grind higher."
The Standard & Poor's 500 index rose 13.09 points, or 0.7 percent, to 1,973.32. The Dow Jones industrial average gained 129.47 points, or 0.8 percent, to 16,956.07. The index climbed as high as 16,998.70 in early afternoon trading before falling back slightly.
The Nasdaq composite rose 50.47, or 1.1 percent, to 4,458.65.
Stocks climbed from the open after HSBC said its Chinese purchasing managers index rose to 50.7 in June from 49.4 a month earlier.
Numbers above 50 signal growth. The market added to its gains after a separate survey showed that U.S. manufacturing kept growing, even as the pace of the expansion slowed from May.
Gains for the stock market were broad and nine of the 10 industry sectors that make up the S&P 500 rose on Tuesday. Utilities were the only sector to fall.
Health care stocks logged the biggest advance. The gains being led by Regeneron. The drug maker rose $19.53, or 7 percent, to $301.94 after the French drugmaker Sanofi said in a regulatory filing that it had raised its stake in the company to 22.5 percent from about 20 percent in April. Sanofi and Regeneron are collaborating on drug research and have an agreement that Sanofi won't acquire more than a 30 percent stake in the company.
The Standard & Poor's 500 index has now gained 6.8 percent this year, after jumping almost 30 percent a year ago. While stocks are no longer cheap after their recent gains, they are still a compelling investment compared to buying bonds or holding cash with interest rates close to zero, said Joe Tanious, a global market strategist at JPMorgan Funds.